• 23andMe and TrialSpark Announce Request for Clinical Trial Proposals

    One year ago - By Surgical Aesthetics Magazine

    23andMe, the consumer genetics company, and TrialSpark, a technology company that helps physician practices become clinical trial sites, are announcing a joint clinical trial offering that combines the power of 23andMe's crowdsourced research platform and extensive database of consenting customers with TrialSpark's distributed site network and trial services.
    To kick off this new offering, the two companies are announcing a request for clinical trial proposals from sponsors interested in accelerating the pace, quality and experience of end-to-end Phase II or Phase IV clinical trials in the...
    Read more ...